Publication | Closed Access

Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction

OncologyHyoscine ButylbromideGastrointestinal PharmacologyMedicineGastroenterologyPathologyGastrointestinal SymptomsClinical GastroenterologyGastrointestinal PathologyUlcerative ColitisInoperable Bowel ObstructionPharmacologyCancer Research